Navigation Links
Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
Date:7/26/2013

SAN DIEGO, July 26, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce financial results for the second quarter ended June 30, 2013, on Tuesday, August 6, 2013 after the markets close. The announcement will be followed by a live webcast and conference call at 5:00 p.m. Eastern time (2:00 p.m. Pacific time).

Orexigen management will host the call and webcast to discuss financial results and recent business highlights. The live call may be accessed by phone by calling (888) 895-5479 (domestic) or (847) 619-6250 (international), participant code 35366685. The webcast can be accessed live on the Investor Relations section of the Orexigen web site at www.orexigen.com and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com

McDavid Stilwell
Vice President, Corporate Communications & Business Development
858-875-8600


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
2. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
4. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
5. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
6. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
7. Orexigen Therapeutics to Present at Upcoming Investor Conferences
8. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
11. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... EAST BRUNSWICK, N.J., Feb. 17, 2012  Savient Pharmaceuticals, Inc. (NASDAQ: ... Vice President and Chief Financial Officer of Savient will present ... February 28, 2012 at 8:30 AM Eastern Time.  The conference ... York City. A live webcast of the presentation ...
... (Nasdaq: ENDP ) today announced that Mark Gottlieb, ... the J.P. Morgan Annual Global High Yield & Leveraged Finance ... The conference will be held at the Loews Hotel in ... archive of the presentation will be available on the company,s ...
Cached Medicine Technology:Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... 2014U.S. military personnel who served in Iraq and ... brain injury (TBI) were compared to military personnel ... reasons. Differences in measures of overall disability, cognitive ... injury are reported in an article in ... Mary Ann Liebert, Inc., publishers. The article is ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2
... Air pollution could be putting patients with heart disease at ... , A study by the University of Edinburgh and Ume ... blood vessel function in men who have previously experienced a ... Heart Foundation and published in the New England Journal of ...
... Armed with satellite imagery, field samples, human Lyme disease ... from the University of New Hampshire, the New Hampshire ... sector will conduct work on the ecology and risk ... states in an effort to eventually identify "hot spots" ...
... Quilt a ,Beautiful Symbol, NEW YORK, Sept. 12 ... Bolds, as "a homemaker." Doing,everything the old-fashioned way, Aylene ... a clothes line, washing and drying her dishes,by hand, ... aroma from the kitchen met you at the front ...
... Where do personal,trainers go to gain more knowledge? Well, ... sciences relating to fitness from conferences, trade,associations and certifying ... list. PersonalTrainerTV.com is a new membership web site for,fitness ... from leading,experts in the industry. According to its ...
... 2007 Approximately 30% of Canadians suffer daily from ... the intensity, but all chronic pain is debilitating and ... Lamb, a clinician nurse at the Pain Centre of ... Shir, the Director of the Centre, shows that methadone ...
... PORTLAND, Maine, Sept. 12 JHA has released the ... Survey. This leading,benchmarking survey reports group Long Term Disability ... premium results for the first,half of the year. The ... of the top twenty carriers, as ranked by inforce ...
Cached Medicine News:Health News:Diesel exhaust may increase risk in patients with heart disease 2Health News:UNH, state health agency, private industry and NASA to tackle Lyme disease 2Health News:UNH, state health agency, private industry and NASA to tackle Lyme disease 3Health News:UNH, state health agency, private industry and NASA to tackle Lyme disease 4Health News:Alzheimer's Foundation of America to Display Quilt to Remember in Los Angeles 2Health News:Alzheimer's Foundation of America to Display Quilt to Remember in Los Angeles 3Health News:Methadone and systematic follow-up: the best solution for managing chronic pain 2Health News:JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: